Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Aethlon Medical Earnings Perspective: Return On Capital Employed

Aethlon Medical (NASDAQ:AEMD) brought in sales totaling $13.12 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 49.75%, resulting in a loss of $3.79 million. In Q3, Aethlon Medical brought in $17.12 thousand in sales but lost $2.53 million in earnings.

Why Is ROCE Significant?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.